Allurion Technologies Inc (ALUR)

$0.7

-0.04

(-4.94%)

Market is closed - opens 8 PM, 08 Nov 2024

Performance

  • $0.70
    $0.78
    $0.70
    downward going graph

    0.0%

    Downside

    Day's Volatility :10.21%

    Upside

    10.21%

    downward going graph
  • $0.55
    $4.64
    $0.70
    downward going graph

    20.94%

    Downside

    52 Weeks Volatility :88.07%

    Upside

    84.91%

    downward going graph

Returns

PeriodAllurion Technologies IncIndex (Russel 2000)
3 Months
-0.71%
0.0%
6 Months
-64.07%
0.0%
1 Year
-82.75%
0.0%
3 Years
-89.79%
-27.4%

Highlights

Market Capitalization
45.4M
Book Value
-$1.47
Earnings Per Share (EPS)
-0.78
Wall Street Target Price
2.38
Profit Margin
-78.56%
Operating Margin TTM
-67.53%
Return On Assets TTM
-83.88%
Return On Equity TTM
0.0%
Revenue TTM
47.6M
Revenue Per Share TTM
1.03
Quarterly Revenue Growth YOY
-9.2%
Gross Profit TTM
0.0
EBITDA
-65.3M
Diluted Eps TTM
-0.78
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.28
EPS Estimate Next Year
-0.42
EPS Estimate Current Quarter
-0.24
EPS Estimate Next Quarter
-0.14

Analyst Recommendation

Buy
    87%Buy
    12%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Allurion Technologies Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 240.0%

Current $0.70
Target $2.38

Technicals Summary

Sell

Neutral

Buy

Allurion Technologies Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Allurion Technologies Inc
Allurion Technologies Inc
4.99%
-64.07%
-82.75%
-89.79%
-89.79%
Stryker Corporation
Stryker Corporation
6.92%
11.1%
34.19%
33.92%
83.79%
Boston Scientific Corp.
Boston Scientific Corp.
2.4%
17.72%
65.69%
99.4%
112.28%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
1.87%
-23.4%
-1.17%
-45.0%
-16.12%
Abbott Laboratories
Abbott Laboratories
3.03%
10.01%
23.21%
-7.89%
40.06%
Medtronic Plc
Medtronic Plc
3.53%
10.02%
24.32%
-26.75%
-15.63%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Allurion Technologies Inc
Allurion Technologies Inc
NA
NA
NA
-0.28
0.0
-0.84
NA
-1.47
Stryker Corporation
Stryker Corporation
39.37
39.39
2.58
12.05
0.19
0.07
0.01
52.86
Boston Scientific Corp.
Boston Scientific Corp.
70.02
70.11
1.55
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
28.26
27.86
6.12
2.53
0.22
0.12
NA
12.35
Abbott Laboratories
Abbott Laboratories
36.09
35.68
2.28
4.67
0.15
0.06
0.02
22.94
Medtronic Plc
Medtronic Plc
30.27
29.99
1.66
5.2
0.08
0.04
0.03
37.39
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Allurion Technologies Inc
Allurion Technologies Inc
Buy
$44.6M
-89.79%
NA
-78.56%
Stryker Corporation
Stryker Corporation
Buy
$140.0B
83.79%
39.37
16.34%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$124.9B
112.28%
70.02
11.26%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$40.2B
-16.12%
28.26
65.86%
Abbott Laboratories
Abbott Laboratories
Buy
$205.7B
40.06%
36.09
13.99%
Medtronic Plc
Medtronic Plc
Buy
$115.5B
-15.63%
30.27
12.06%

Insights on Allurion Technologies Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 8.23M → 11.76M (in $), with an average increase of 16.3% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 5.58M → -2.16M (in $), with an average decrease of 138.7% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 65.7% return, outperforming this stock by 148.4%

Company Information

Organization
Allurion Technologies Inc
Employees
501
CEO
Dr. Shantanu K. Gaur M.D.
Industry
Miscellaneous

FAQs